AI tool for computing radiation dose helps personalize prostate cancer treatment

MedicalXpress | أغس 04, 2026

Radiopharmaceutical therapy (RPT) has made significant strides over the past 50 years, although it only recently received FDA approval to treat prostate cancer. But despite the progress—and billions of dollars in industry investments—one area that has lagged behind is dosing, which is still one-size-fits-all. Now, researchers at the University of Massachusetts Amherst have developed an AI model that can inform individualized treatment by generating a patient's radiation dose map with gold-standard accuracy in under 23 seconds.